OnKure Therapeutics (OKUR) Common Equity (2020 - 2026)
OnKure Therapeutics' Common Equity came in at $172.11 million for Q2 2026, up 120.2% from $78.17 million a year earlier but down 6.6% from the prior quarter.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, OnKure Therapeutics' Common Equity was $56.18 million, down 45.9% from FY2024.
- Going back by year, Common Equity was $103.83 million in FY2024, -$101.84 million in FY2023, -$54.42 million in FY2022 and $147.21 million in FY2021.
- The five-year range for quarterly Common Equity is -$135.05 million (Q3 2024) to $184.35 million (Q1 2026).
- The fastest year-over-year change in Common Equity over five years came in Q2 2026 (growth of 120.2%), and the weakest in Q4 2025 (a decline of 45.9%).
- Business Quant data shows OKUR's Common Equity at $184.35 million (Q1 2026), $56.18 million (Q4 2025) and $66.43 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | OnKure Therapeutics | 136.90 Mn | -454.00 Mn | - | 157.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 157.74 Mn |
| Jun 30, 2026 | 172.11 Mn |
| Mar 31, 2026 | 184.35 Mn |
| Dec 31, 2025 | 56.18 Mn |
| Sep 30, 2025 | 66.43 Mn |
| Jun 30, 2025 | 78.17 Mn |
| Mar 31, 2025 | 90.65 Mn |
| Dec 31, 2024 | 103.83 Mn |
| Sep 30, 2024 | -135.05 Mn |
| Jun 30, 2024 | -123.58 Mn |
| Mar 31, 2024 | -111.26 Mn |
| Dec 31, 2023 | -101.84 Mn |
| Sep 30, 2023 | 114.94 Mn |
| Jun 30, 2023 | 132.53 Mn |
| Mar 31, 2023 | 87.08 Mn |
| Dec 31, 2022 | -54.42 Mn |
| Sep 30, 2022 | 112.05 Mn |
| Jun 30, 2022 | 124.16 Mn |
| Mar 31, 2022 | 135.32 Mn |
| Dec 31, 2021 | 147.21 Mn |
API Access
OnKure Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();